Breaking News

You are here » Indian-Commodity  :  Commodities  :  Jeera Commodity Lengthen Its 2 Days Dropping Streak


Jeera Commodity Lengthen Its 2 Days Dropping Streak

Lower exchanging activities held the trend poor regarding Jeera , that prolonged their 2 day dropping ability on Thursday. Earnings reserving at better stages amongst deficiency of requirement for the item in mandis mostly added to the drop in the costs of jeera. However, according to information, some purchasing activities might be announced in the getting weeks at these reduce levels as arrivals of superior quality crop might give assist to rates.

The settlement for May supply was buying and selling at Rs 14,150.00, lower by 1.24% or Rs 178.00 from their prior finishing of Rs 14,328.00. The available interest of settlement was standing at 10,239 lots.

The deal for June delivery was exchanging at Rs 14,820.00, lower by 0.99% or Rs 148.00 from their last ending of Rs 14,968.00. The available interest of settlement was standing at 21,354 lots on NCDEX.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......